Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: A changing pattern at the hospital for tropical diseases, London

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Fletcher, Kate ^a   Issa, Rita ^a   Lockwood, D N J ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; DNA; IMMUNOMODULATING AGENT; STIBOGLUCONATE SODIUM;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; FEMALE; FEVER; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; LEISHMANIA; MALE; PANCYTOPENIA; RETROSPECTIVE STUDY; RISK FACTOR; SERODIAGNOSIS; SPLENOMEGALY; TRAVEL; UNITED KINGDOM; VISCERAL LEISHMANIASIS; ADOLESCENT; ENGLAND; HOSPITAL; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD; TROPICAL MEDICINE; VERY ELDERLY; YOUNG ADULT;

PHLEBOTOMINAE; PROTOZOA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, SPECIAL; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIASIS, VISCERAL; LONDON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TROPICAL MEDICINE; YOUNG ADULT;

EID: 84926513082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121418     Document Type: Article

References (19)

1. Mabey D, Gill G, Parry E, Weber MW, Whitty JM. Principles of Medicine in Africa Fourth Edition. Cambridge University Press. 2013
2. World Health Organization website. Leishmaniasis disease burden. Available: http://www.who.int/ leishmaniasis. Accessed 10 July 2013
3. Malik ANJ, John L, Bryceson ADM, Lockwood DNJ. Changing pattern of Visceral Leishmaniasis, United Kingdom, 1985-2004. Emerging Infectious Diseases. 2006; 12: 8
4. Nylen S, Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends in Immunlogy. 2007; 28: 378-84 PMID: 17689290
5. Blackwell JM. Genetic susceptibility to leishmanial infection. Studies in mice and man. Parasitology 1996; 112: S67-S74 PMID: 8684837
6. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in Leishmaniasis. Lancet. 2005; 366: 1561-77 PMID: 16257344
7. Venizelos I, Tatsiou Z, Papthomas TG, Orazi A. Visceral Leishmaniasis in a rheumatoid arthritis patient treated with methotrexate. International Journal of Infectious Diseases. 2009; 13: e169-e172 doi: 10. 1016/j.ijid.2008.09.012 PMID: 19026580
8. Bogdan C. Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Annals of Rheumatological Disease. 2012; 71 (II): i60-i66
9. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, et al. Leishmania and Human Immunodeficiency Virus Coinfection: the First 10 Years. Microbiology Reviews. 1997: 298-319
10. Monge-Maillo B, Norman FF, Cruz I, Alvar J, Lopez-Velez R. Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region. PLOS Neglected Tropical Diseases. 2014; 8(8): e3021 doi: 10.1371/ journal.pntd.0003021 PMID: 25144380
11. Argaw D, Mulugeta A, Herrero M, Nombela N, Teklu T, Tefera T, et al. Risk Factors for Visceral Leishmaniasis among Residents and Migrants in Kafta-Humera, Ethiopia. PLOS Neglected tropical diseases. 2013; 7(11): e2543 doi: 10.1371/journal.pntd.0002543 PMID: 24244778
12. Wall EC, Watson J, Armstrong M, Chiodini PL, Lockwood DN. Epidemiology of Imported Cutaneous Leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of Polymerase Chain Reaction to Identify the Species. American Journal of Tropical Medicine and Hygiene. 2012; 86 (1): 115-118 doi: 10.4269/ajtmh.2012.10-0558 PMID: 22232460
13. Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet. 1998; 21; 351(9102): 563-5. PMID: 9492776
14. Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'Keeffe C and Davidson RN. Evaluation of a new recombinant k39 rapid diagnostic test for Sudanese visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 2006; 74(1): 76-80 PMID: 16407349
15. Rosenthal E, Tempesta S, Del Guidice P, Marty P, Desjeux P, Pradier C, et al. Declining incidence of visceral leishmaniasis in HIV-infected individuals in era of highly active antiretroviral therapy. AIDS. 2001; 15:1184-1185 PMID: 11416724
16. Weisser M, Khanlari B, Terracciano L, Arber C, Gratwohl A, Bassetti S, et al. Visceral Leishmaniasis: A threat to immunocompromised patients in non-endemic areas? Clinical Microbiology and infection. 2007; 13: 751-753 PMID: 17610597
17. Pavli A, Maltezou HC. Leishmaniasis, an emerging infection in travellers. International Journal of Infectious diseases. 2010; 14:e1032-e1039 doi: 10.1016/j.ijid.2010.06.019 PMID: 20952234
18. Szabo G. Consequences of Alcohol consumption. Alcohol and alcoholism. 1999; 34 (6): 830-841 PMID: 10659718
19. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycaemia in Hospitals. Diabetes Care. 2004; 27: